Here, we demonstrate the ability of 12 to selectively inhibit the Gli1 mRNA expression and the proliferation of Hh-dependent tumor cells in vitro and in vivo, including MB and BCC, two tumor models where Hh pathway activity occurs by ligand-independent manner. This evidence concerns the gene GLI1 and skin basal cell carcinoma.